SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
-
Page/Page column 48
(2009/09/05)
SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
-
Page/Page column 37
(2008/06/13)
More Articles about upstream products of 1175065-56-1